CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

about

Q57291677

sameAs

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

Item

http://www.wikidata.org/entity/Q57291663

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

@en

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

@nl

type

Item

label

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

@en

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

@nl

prefLabel

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

@en

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

@nl

P1476

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

@en

P2093

Carrie Peltz

http://www.w3.org/2001/XMLSchema#string

Michael R Sierks

http://www.w3.org/2001/XMLSchema#string

Philip Schulz

http://www.w3.org/2001/XMLSchema#string

Stephanie M Williams

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury

Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia

Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.

Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.

Isolating recombinant antibodies against specific protein morphologies using atomic force microscopy and phage display technologies.

Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity

Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cells.

Detecting morphologically distinct oligomeric forms of alpha-synuclein.

P304

702-709

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000006322

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kristine Yaffe

P577

2018-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30297502

http://www.w3.org/2001/XMLSchema#string

P932

6177276

http://www.w3.org/2001/XMLSchema#string

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

about

sameAs

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932